Regulation of average 24 h human plasma leptin level the influence of exercise and physiological changes in energy balance

International Journal of Obesity

Volumn 23, Issue 2, 1999, Pages 151-158

  Van Aggel Leijssen, Dorien P C ^a   Van Baak, M A ^a   Tenenbaum, R ^b   Campfield, L A ^b   Saris, W H M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Hoffman La Roche Department of Metabolic Diseases   (United States)

Author keywords

Energy expenditure; Energy restriction; Insulin; Overfeeding; Short term

Indexed keywords

CATECHOLAMINE DERIVATIVE; FATTY ACID; GLUCOSE; INSULIN; LEPTIN; PROTEIN;

ARTICLE; CATECHOLAMINE BLOOD LEVEL; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENERGY BALANCE; EXERCISE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; MALE; MALNUTRITION; NORMAL HUMAN; PRIORITY JOURNAL; ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EATING; ENERGY METABOLISM; METABOLISM; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; REGRESSION ANALYSIS;

ADULT; CIRCADIAN RHYTHM; EATING; ENERGY METABOLISM; EXERCISE; HUMANS; LEPTIN; MALE; PROTEINS; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 0032908236     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800784     Document Type: Article

References (43)

1. 1 Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
2. 2 Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin SA, Bauer TTL, Rosato E, Colberg J, Caro JF. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 1995; 95: 2986-2988.
3. 3 Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K. Human obese gene expression; adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995; 44: 855-858.
4. 4 Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
5. 5 Halaas JL, Gaijwala K, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
6. 6 Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
7. 7 Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck PR, Schoner B, Smith D, Tinsley FC, Zhang XY, Heiman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-532.
8. 8 Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ, Weigle DS. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45: 531-535.
9. 9 Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997; 385: 165-168.
10. 10 Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Target disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-141.
11. 11 Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Engl J Med 1996; 334: 292-295.
12. 12 Frederich RC, Hamann A, Anderson S, Löllmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-1314.
13. 13 Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-1161.
14. 14 Hickey MS, Considine RV, Israel RG, Mahar TL, McCammon MR, Tyndall GL, Houmard JA, Caro JF. Leptin is related to body fat content in male distance runners. Am J Physiol 1996; 271: E938-E940.
15. 15 Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: The tale of an obesity gene. Diabetes 1996; 45: 1455-1462.
16. 16 Kolaczynski JW, Considine RV, Ohannesian J, Considine, RV, Marco CC, Caro JF. Responses of leptin to short-term fasting and refeeding in humans. Diabetes 1996; 45: 1511-1515.
17. 17 Considine RV. Invited editorial on 'acute and chronic effects of exercise on leptin levels in humans'. J Appl Physiol 1997; 83: 3-4.
18. 18 Matkovic V, Ilich JZ, Badenhop NE, Skugor M, Clairmont A. Klisovic D, Landoll JD. Gain in body fat is inversely related to the noctural rise in serum leptin level in young females. J Clin Endocrinol Metab 1997; 82: 1368-1372.
19. 19 Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Marco C, Caro JF. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996; 97: 1344-1347.
20. 20 Schoeller DA, Cella LK, Sinha MK, Caro JF. Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest 1997; 100: 1882-1887.
21. 21 Sinha MK, Sturis J, Ohannesian J, Magosin S, Stephens T, Heiman ML, Polonsky KS, Caro JF. Ultradian oscillations of leptin secretion in humans. Biochem Biophys Res Commun 1996; 228: 733-738.
22. 22 Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong ML, Bongiorno PB, Chrousos GP, Karp B, Allen C, Flier JS, Gold PW. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 1997; 3: 575-579.
23. 23 Kolaczynski JW, Ohannesian JP, Considine RV, Marco CC, Caro JF. Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab 1996; 81: 4162-4165.
24. 24 Boden G, Chen X, Kolaczynski JW, Polansky M. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 1997; 100: 1107-1113.
25. 25 Korbonits M, Trainer PJ, Little JA, Edwards R, Kopelman PG, Besser GM, Svec F, Grossman AB. Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity. Clin Endocrinol 997; 46: 751-757.
26. 26 Pérusse L, Collier G, Gagnon J, Leon AS, Rao DC, Skinner S, Wilmore JH, Nadeau A, Zimmet PZ, Bouchard C. Acute and chronic effects of exercise on leptin levels in humans. J Appl Physiol 1997; 83: 5-10.
27. 27 Racette SB, Coppack SW, Landt M, Klein S. Leptin production during moderate-intensity aerobic exercise. J Clin Endocrinol Metab 1997; 82: 2275-2277.
28. 28 Voedingsraad. Nederlandse voedingsnormen 1989. Voorlichtingsbureau voor de voeding: Den Haag, 1992, 291.
29. 29 Anonymous. Zo eet Nederland. Resultaten van de voedselconsumptiepeiling 1992. Voorlichtingsbureau voor de voeding: Den Haag, 1993, 57.
30. 30 Siri WE. The gross composition of the body. Adv Biol Med Physiol 1956; 4: 239-280.
31. 31 Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949; 109: 1-9.
32. 32 Smith FS, Campfield LA. Pancreatic adaptation in VMH obesity: in vivo compensatory responses to altered neural input. Am J Physiol 1986; 251: R70-R76.
33. 33 Smedes F, Kraak JC, Poppe H. Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J Chromatogr 1982; 231: 25-39.
34. 34 Halberg F, Halberg E. Appendix: Terms for methods and facts in chronopharmacology. In: Takahashi R, Halberg F, Walker CA (eds). Towards chronopharmacology. Pergamon Press: Oxford, 1982, 391-423.
35. 35 Laughlin GA, Yen SSC. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. J Clin Endocrinol Metab 1997; 82: 318-321.
36. 36 Donahoo WT, Jensen DR, Yost TJ, Ecker RH. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism reglating leptin secretion. J Clin Endocrinol Metab 1997; 82: 4139-4143.
37. 37 Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M. Plasma leptin and insulin relationship in obese and nonobese humans. Diabetes 1996; 45: 695-698.
38. 38 Malmström R, Taskinen MR, Karonen SL, Yki-Järvinen H. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 1996; 39: 993-996.
39. 39 Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JF. Acute and chronic effect of insulin on leptin production in humans; studies in vivo and in vitro. Diabetes 1996; 45: 699-701.
40. 40 Muscelli E, Camastra S, Masoni A, Baldi S, Sironi AM, Natali A, Ferrannini E. Acute insulin administration does not affect plasma leptin levels in lean or obese subjects. Eur J Clin Invest 1996; 26: 940-943.
41. 41 Tataranni PA, Pratley R, Maffei M, Ravussin E. Acute and prolonged administration of glucocorticoids (methylprednisolone) does not affect plasma leptin concentration in humans. Int J Obes 1997; 21: 327-330.
42. 42 Masuzaki H, Ogawa Y, Hosoda K, Miyawaki T, Hanaoka I, Hiraoka J, Yasuno A, Nishimura H, Yoshimasa Y, Nishi S, Nakao K. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab 1997; 82: 2542-2547.
43. 43 Dubuc GR, Phinney SD, Stern JS, Havel PJ. Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metab Clin Exp 1998; 47: 429-434.